Trajan Group Holdings Ltd
ASX:TRJ
Intrinsic Value
Trajan Group Holdings Ltd. engages in the designing, manufacturing and supply of products and solutions that enhance scientific measurement. [ Read More ]
There is not enough data to reliably calculate the intrinsic value of TRJ.
Fundamental Analysis
Balance Sheet Decomposition
Trajan Group Holdings Ltd
| Current Assets | 69.7m |
| Cash & Short-Term Investments | 11.1m |
| Receivables | 24.2m |
| Other Current Assets | 34.4m |
| Non-Current Assets | 159.3m |
| Long-Term Investments | 1.6m |
| PP&E | 36.9m |
| Intangibles | 114.3m |
| Other Non-Current Assets | 6.5m |
| Current Liabilities | 39.2m |
| Accounts Payable | 9.6m |
| Accrued Liabilities | 13.9m |
| Other Current Liabilities | 15.7m |
| Non-Current Liabilities | 60.3m |
| Long-Term Debt | 49.5m |
| Other Non-Current Liabilities | 10.8m |
Earnings Waterfall
Trajan Group Holdings Ltd
|
Revenue
|
162.2m
AUD
|
|
Cost of Revenue
|
-95.1m
AUD
|
|
Gross Profit
|
67.1m
AUD
|
|
Operating Expenses
|
-57.7m
AUD
|
|
Operating Income
|
9.4m
AUD
|
|
Other Expenses
|
-7.5m
AUD
|
|
Net Income
|
1.9m
AUD
|
Free Cash Flow Analysis
Trajan Group Holdings Ltd
What is Free Cash Flow?
TRJ Profitability Score
Profitability Due Diligence
Trajan Group Holdings Ltd's profitability score is 48/100. The higher the profitability score, the more profitable the company is.
Score
Trajan Group Holdings Ltd's profitability score is 48/100. The higher the profitability score, the more profitable the company is.
TRJ Solvency Score
Solvency Due Diligence
Trajan Group Holdings Ltd's solvency score is 45/100. The higher the solvency score, the more solvent the company is.
Score
Trajan Group Holdings Ltd's solvency score is 45/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
TRJ Price Targets Summary
Trajan Group Holdings Ltd
According to Wall Street analysts, the average 1-year price target for TRJ is 1.84 AUD with a low forecast of 1.41 AUD and a high forecast of 2.31 AUD.
Shareholder Return
TRJ Price
Trajan Group Holdings Ltd
| Average Annual Return | 24.88% |
| Standard Deviation of Annual Returns | 116.24% |
| Max Drawdown | -78% |
| Market Capitalization | 168.8m AUD |
| Shares Outstanding | 152 216 000 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Trajan Group Holdings Ltd. engages in the designing, manufacturing and supply of products and solutions that enhance scientific measurement. The firm is developing and manufacturing analytical science instruments, devices and solutions used in the analysis of biological, food and environmental samples. The firm is focused on serving life science, biopharmaceutical, and analytical companies in the United States, Australia, Europe, and Asia. The firm is operating in two segments, which includes Analytical Products and Life Science Solutions. Its Analytical Products include Metal syringes, Gas tight syringes, eVol, liquid extraction (uLLE), Electrokinetic extraction (EkE), Ferrules, Microfluidics, Emitter tips, Septa and caps and Porous polymer monoliths. Its Life Science Solutions include Dispensing syringes, Microscope slides, Coverslips, Slide and cassette storage, Liquid powder dispensing, Infusion automation, hemaPEN, Microbiopsy and Hummingbird. The company also offers micro-biopsy device for skin sampling, including Mitra device.
You don't have any saved screeners yet
